Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
06/2010
06/02/2010CN101717370A New method for preparing 2-n-propyl-4-methyl-6-(1-methyl benzimidazole-2-yl) benzimidazole
06/02/2010CN101717369A Method for preparing arylamine by catalysis in aqueous phase
06/02/2010CN101266847B 2-mercaptobenzimidazole application for anti-oxidation on the surface of the cable conductor
06/01/2010US7728026 2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
06/01/2010US7728005 such as N-(2-bromophenyl)-N'-[2-(4-fluorophenoxy)ethyl]urea, having superior antiinflammatory and analgesic activity
06/01/2010CA2448737C Viral polymerase inhibitors
05/2010
05/27/2010WO2010058995A1 Electroluminescent device using the electroluminescent compounds
05/27/2010WO2010058512A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
05/27/2010US20100130748 Snar process for preparing benzimidazole compounds
05/27/2010US20100130737 Regulating Agent of GPR34 Receptor Function
05/27/2010US20100130570 Fungicide n-5-membered fused heteroaryl-methylene-n-cycloalkyl-carboxamide derivatives
05/27/2010US20100130545 Bridged six-membered ring compounds
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100126378 Pigments for Non-Aqueous Inks and Coatings
05/27/2010CA2744012A1 Glycogen synthase kinase-3 beta inhibitors containing 7-hydroxy-benzoimidazole-4-yl-methanone derivatives
05/26/2010EP2189457A1 Novel synthesis of irbesartan
05/26/2010EP2188263A1 Benzimidazole derivatives used as fxr agonists
05/26/2010EP1651613B1 4,5-dihydro-imidazole as p2x7 ion channel blockers
05/25/2010US7723527 Benzoimidazole compounds
05/25/2010US7723526 Benzoimidazole compounds
05/25/2010US7723359 such as 2-{5-Bromo-2-[4-(1-methyl-piperidin-4-yl)-butoxy]-pyridin-4-yl}-4-methyl-1H-benzoimidazole, used in leukocyte recruitment inhibition, modulation of histamine H4 receptors and in treating conditions such as inflammation
05/20/2010WO2010056644A1 1- (ARYLSULFONYL) -4- (PI PERAZIN-I -YL) -IH-BENZ IMIDAZOLES AS δ-HYDROXYTRYPTAMINE- 6 LIGANDS
05/20/2010WO2010055129A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010WO2010055125A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
05/20/2010CA2740262A1 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/19/2010EP2185543A2 Method for splitting omeprazole salts
05/19/2010EP2185502A1 Pyridinecarboxamide and benzamide derivatives as taar1 ligands
05/18/2010US7718722 Alkylthio- and aryl(heteroyl)thio-substituted p-phenylenediamines, their manufacture and their use in rubber
05/14/2010WO2010054330A2 Monofunctional carbocyanine dyes for in vivo and in vitro imaging
05/14/2010WO2010053583A2 Small molecule cd4 mimetics and uses thereof
05/14/2010WO2010053233A1 The new telmisartan zinc salt and the preparation thereof
05/14/2010WO2010052670A1 PROCESS TO PREPARE NEW SUBSTITUTED 1H-BENZO [d] IMIDAZOL-2(3H)-ONES, NEW INTERMEDIATES AND THEIR USE AS BACE 1 INHIBITORS
05/14/2010WO2010009405A3 Targeted nitroxide agents
05/13/2010US20100121050 Processes for making zilpaterol and salts thereof
05/13/2010US20100120880 PROCESS TO PREPARE NEW SUBSITUTED 1H-BENZO[d]IMIDAZOL-2(3H)-ONES, NEW INTERMEDIATES AND THEIR USE AS BACE 1 INHIBITORS
05/13/2010US20100120802 Novel Anti-Inflammatory and Analgesic Heterocyclic Amidines that Inhibit Nitrogen Oxide (NO) Production
05/12/2010EP2184276A1 Process to prepare new substituted 1H-Benzo(d) imidazol-2(3h)-Ones, New intermediates and their use as bace 1 inhibitors
05/12/2010EP2184272A1 Piperazine derivative
05/12/2010EP2183222A2 Azoloraine derivatives, method for the production thereof, pharmaceuticals containing these compounds, and the use thereof
05/12/2010EP2183217A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/12/2010EP2183213A2 Optically active (r)-aryloxypropionic acid amides and herbicidal composition comprising same
05/12/2010EP1173169B1 Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and the use thereof
05/12/2010CN1958576B Acid ion liquid of benzimidazole salts, synthetic method, and application in reaction of esterification
05/12/2010CN1919844B Method for aqueous phase oxo-synthesis of iansoprazole
05/12/2010CN1919839B Preparation technique of 2-chloromethylbenzimidazole
05/12/2010CN1867336B 1-aryl-4-substituted piperazines derivatives and pharmaceutical use thereof
05/12/2010CN1863788B Antibacterial and radiation proof compound
05/12/2010CN101705245A Non-viral gene vector of poly-benzimidazole metal complex and preparation and application thereof
05/12/2010CN101704810A Cycloalkyl inhibitors of potassium channel function
05/12/2010CN101704789A Purifying method of high purity carbendazim standard product
05/12/2010CN101704788A Improved preparation process of 2-Butyl-1,3-diazapira[4,4]nonane-1-en-4-one
05/12/2010CN101172968B 2-propyl-4 methyl-6-(tolimidazole-2group) benzoglioxaline salt and method for producing the same
05/11/2010US7714141 Processes for production of optically active PPAR-activating compounds and intermediates for production thereof
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714010 N-[5-(2-Cyclopropoxy-ethyl)-7,7-dimethyl-6-oxo-3,5,6,7-tetrahydro-imidazo[4,5-f]indol-2-yl]-benzamide; tubulin-binding molecules
05/11/2010US7714009 Nitrogen-containing fused heterocyclic compounds
05/11/2010US7713975 Syk-mediated disease such as allergic conjunctivitis; vernal conjunctivitis; vernal keratoconjunctivitis; and giant papillary conjunctivitis
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/06/2010WO2010050779A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010US20100113548 Antagonists of bitter taste receptors and uses thereof
05/06/2010US20100113545 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113423 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
05/06/2010US20100109514 Heterocyclic bridged biphenyls
05/06/2010CA2741988A1 7-hydroxy-benzoimidazole-4-yl-methanone derivatives and pbk inhibitors containing the same
05/05/2010EP2181987A1 Heterocyclic compound and use thereof
05/05/2010CN1630629B 酯化合物及其医药用途 Ester compounds and pharmaceutical use
05/05/2010CN101048382B New indole or benzimidazole derivatives
05/04/2010US7709519 2-(1,3-Dihydro-2H-benzimidazol-2-ylidene)-1-[3-(1,2-dihydroxyethyl)phenyl]-3-(3,4,5-trifluorophenyl)propane-1,3-dione; GnRH receptor antagonism; prostate cancer, breast cancer, endometriosis, uterine leiomyoma, benign prostatic hypertrophy; good availability by oral administration
05/04/2010US7709518 Compounds for inflammation and immune-related uses
05/04/2010US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis
05/04/2010US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
05/04/2010CA2427608C Condensed pyradizindione derivatives as pde inhibitors
04/2010
04/29/2010WO2010047674A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
04/29/2010WO2010046857A1 Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl
04/29/2010WO2010046855A1 Bridged tetrahydronaphthalene derivatives
04/29/2010WO2010028032A3 Process for synthesis of imidazolium and benzimidazolium surfactants and their use in clays and nanocomposites
04/29/2010US20100105749 Chemical compounds, pharmaceutical compositions and methods
04/29/2010US20100105712 Chemical compounds
04/29/2010US20100104966 Crystal phase of a benzimidazolone azo pigment
04/29/2010CA2741030A1 Low molecular weight thyroid stimulating hormone receptor (tshr) agonists
04/29/2010CA2740722A1 Salts of isobutyric acid (1 r*, 2r*, 4r* ) -2- (2-{ [3- (4, 7-dimeth0xy-1 h-benzoimidazol-2-yl) -propyl] -methyl-amino } -ethyl) -5-phenyl-bicyclo [2.2.2] oct-5- en- 2 -yl
04/29/2010CA2740430A1 Bridged tetrahydronaphthalene derivatives
04/28/2010EP2179984A1 Acrylamido derivatives useful as inhibitors of the mitochondrial permeability transition
04/28/2010EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
04/28/2010EP1907366B1 New imidazole derivatives, preparation method thereof and organic electronic device using the same
04/28/2010EP1470111B1 Method for the production and purification of 1,7'-dimethyl-2'-propyl-2,5'-bi-1 h-benzimidazole
04/27/2010US7705149 Benzoimidazole compounds
04/27/2010US7705143 Benzoimidazole compounds
04/27/2010US7705031 Benzimidazoles useful as modulators of ion channels
04/27/2010US7705029 Acrylonitrile derivatives for inflammation and immune-related uses
04/22/2010WO2010045580A1 Sphingosine-1-phosphate receptor antagonists
04/22/2010WO2010045266A1 Therapeutic antiviral peptides
04/22/2010WO2010044585A2 Piperidine compounds, pharmaceutical composition comprising the same and its use
04/22/2010WO2010044441A1 Acetic acid amide derivative having inhibitory activity on vascular endothelial lipase
04/22/2010WO2010044054A1 Phenethylamide derivatives and their heterocyclic analogues
04/22/2010WO2010043513A1 New benzimidazole derivatives
04/22/2010US20100099128 Novel peptidase substrates
04/22/2010CA2740783A1 Sphingosine-1-phosphate receptor antagonists
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 154